The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Neuropathic Eye Pain Market Research Report 2025

Global Neuropathic Eye Pain Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1739162

No of Pages : 86

Ask Your Query

Synopsis
Global Neuropathic Eye Pain market is projected to reach US$ 188.9 million in 2029, increasing from US$ 152 million in 2022, with the CAGR of 3.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Neuropathic Eye Pain market research.

Key companies engaged in the Neuropathic Eye Pain industry include OKYO Pharma, Ocular Therapeutix, Inc., IACTA Pharmaceuticals, Inc., Sun Pharmaceutical Industries Ltd, Novartis AG, SALVAT, AbbVie Inc, Bausch &Lomb Incorporated and Kala Pharmaceuticals, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of Neuropathic Eye Pain were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Neuropathic Eye Pain market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Neuropathic Eye Pain market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • OKYO Pharma
  • Ocular Therapeutix, Inc.
  • IACTA Pharmaceuticals, Inc.
  • Sun Pharmaceutical Industries Ltd
  • Novartis AG
  • SALVAT
  • AbbVie Inc
  • Bausch &Lomb Incorporated
  • Kala Pharmaceuticals
  • Spectra Vision Care
  • AlconLaboratories
  • BRIM Biotechnology Inc

Segment by Type

  • Steroids
  • Antidepressants
  • Anticonvulsants
  • Opioids
  • Others

Segment by Application

  • Clinic
  • Hospital
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)

The Neuropathic Eye Pain report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuropathic Eye Pain Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Steroids
1.2.3 Antidepressants
1.2.4 Anticonvulsants
1.2.5 Opioids
1.2.6 Others
1.3 Market by Application
1.3.1 Global Neuropathic Eye Pain Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neuropathic Eye Pain Market Perspective (2018-2029)
2.2 Neuropathic Eye Pain Growth Trends by Region
2.2.1 Global Neuropathic Eye Pain Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Neuropathic Eye Pain Historic Market Size by Region (2018-2023)
2.2.3 Neuropathic Eye Pain Forecasted Market Size by Region (2024-2029)
2.3 Neuropathic Eye Pain Market Dynamics
2.3.1 Neuropathic Eye Pain Industry Trends
2.3.2 Neuropathic Eye Pain Market Drivers
2.3.3 Neuropathic Eye Pain Market Challenges
2.3.4 Neuropathic Eye Pain Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neuropathic Eye Pain Players by Revenue
3.1.1 Global Top Neuropathic Eye Pain Players by Revenue (2018-2023)
3.1.2 Global Neuropathic Eye Pain Revenue Market Share by Players (2018-2023)
3.2 Global Neuropathic Eye Pain Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neuropathic Eye Pain Revenue
3.4 Global Neuropathic Eye Pain Market Concentration Ratio
3.4.1 Global Neuropathic Eye Pain Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuropathic Eye Pain Revenue in 2022
3.5 Neuropathic Eye Pain Key Players Head office and Area Served
3.6 Key Players Neuropathic Eye Pain Product Solution and Service
3.7 Date of Enter into Neuropathic Eye Pain Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neuropathic Eye Pain Breakdown Data by Type
4.1 Global Neuropathic Eye Pain Historic Market Size by Type (2018-2023)
4.2 Global Neuropathic Eye Pain Forecasted Market Size by Type (2024-2029)
5 Neuropathic Eye Pain Breakdown Data by Application
5.1 Global Neuropathic Eye Pain Historic Market Size by Application (2018-2023)
5.2 Global Neuropathic Eye Pain Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Neuropathic Eye Pain Market Size (2018-2029)
6.2 North America Neuropathic Eye Pain Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Neuropathic Eye Pain Market Size by Country (2018-2023)
6.4 North America Neuropathic Eye Pain Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neuropathic Eye Pain Market Size (2018-2029)
7.2 Europe Neuropathic Eye Pain Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Neuropathic Eye Pain Market Size by Country (2018-2023)
7.4 Europe Neuropathic Eye Pain Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neuropathic Eye Pain Market Size (2018-2029)
8.2 Asia-Pacific Neuropathic Eye Pain Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Neuropathic Eye Pain Market Size by Region (2018-2023)
8.4 Asia-Pacific Neuropathic Eye Pain Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neuropathic Eye Pain Market Size (2018-2029)
9.2 Latin America Neuropathic Eye Pain Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Neuropathic Eye Pain Market Size by Country (2018-2023)
9.4 Latin America Neuropathic Eye Pain Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neuropathic Eye Pain Market Size (2018-2029)
10.2 Middle East & Africa Neuropathic Eye Pain Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Neuropathic Eye Pain Market Size by Country (2018-2023)
10.4 Middle East & Africa Neuropathic Eye Pain Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 OKYO Pharma
11.1.1 OKYO Pharma Company Detail
11.1.2 OKYO Pharma Business Overview
11.1.3 OKYO Pharma Neuropathic Eye Pain Introduction
11.1.4 OKYO Pharma Revenue in Neuropathic Eye Pain Business (2018-2023)
11.1.5 OKYO Pharma Recent Development
11.2 Ocular Therapeutix, Inc.
11.2.1 Ocular Therapeutix, Inc. Company Detail
11.2.2 Ocular Therapeutix, Inc. Business Overview
11.2.3 Ocular Therapeutix, Inc. Neuropathic Eye Pain Introduction
11.2.4 Ocular Therapeutix, Inc. Revenue in Neuropathic Eye Pain Business (2018-2023)
11.2.5 Ocular Therapeutix, Inc. Recent Development
11.3 IACTA Pharmaceuticals, Inc.
11.3.1 IACTA Pharmaceuticals, Inc. Company Detail
11.3.2 IACTA Pharmaceuticals, Inc. Business Overview
11.3.3 IACTA Pharmaceuticals, Inc. Neuropathic Eye Pain Introduction
11.3.4 IACTA Pharmaceuticals, Inc. Revenue in Neuropathic Eye Pain Business (2018-2023)
11.3.5 IACTA Pharmaceuticals, Inc. Recent Development
11.4 Sun Pharmaceutical Industries Ltd
11.4.1 Sun Pharmaceutical Industries Ltd Company Detail
11.4.2 Sun Pharmaceutical Industries Ltd Business Overview
11.4.3 Sun Pharmaceutical Industries Ltd Neuropathic Eye Pain Introduction
11.4.4 Sun Pharmaceutical Industries Ltd Revenue in Neuropathic Eye Pain Business (2018-2023)
11.4.5 Sun Pharmaceutical Industries Ltd Recent Development
11.5 Novartis AG
11.5.1 Novartis AG Company Detail
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Neuropathic Eye Pain Introduction
11.5.4 Novartis AG Revenue in Neuropathic Eye Pain Business (2018-2023)
11.5.5 Novartis AG Recent Development
11.6 SALVAT
11.6.1 SALVAT Company Detail
11.6.2 SALVAT Business Overview
11.6.3 SALVAT Neuropathic Eye Pain Introduction
11.6.4 SALVAT Revenue in Neuropathic Eye Pain Business (2018-2023)
11.6.5 SALVAT Recent Development
11.7 AbbVie Inc
11.7.1 AbbVie Inc Company Detail
11.7.2 AbbVie Inc Business Overview
11.7.3 AbbVie Inc Neuropathic Eye Pain Introduction
11.7.4 AbbVie Inc Revenue in Neuropathic Eye Pain Business (2018-2023)
11.7.5 AbbVie Inc Recent Development
11.8 Bausch &Lomb Incorporated
11.8.1 Bausch &Lomb Incorporated Company Detail
11.8.2 Bausch &Lomb Incorporated Business Overview
11.8.3 Bausch &Lomb Incorporated Neuropathic Eye Pain Introduction
11.8.4 Bausch &Lomb Incorporated Revenue in Neuropathic Eye Pain Business (2018-2023)
11.8.5 Bausch &Lomb Incorporated Recent Development
11.9 Kala Pharmaceuticals
11.9.1 Kala Pharmaceuticals Company Detail
11.9.2 Kala Pharmaceuticals Business Overview
11.9.3 Kala Pharmaceuticals Neuropathic Eye Pain Introduction
11.9.4 Kala Pharmaceuticals Revenue in Neuropathic Eye Pain Business (2018-2023)
11.9.5 Kala Pharmaceuticals Recent Development
11.10 Spectra Vision Care
11.10.1 Spectra Vision Care Company Detail
11.10.2 Spectra Vision Care Business Overview
11.10.3 Spectra Vision Care Neuropathic Eye Pain Introduction
11.10.4 Spectra Vision Care Revenue in Neuropathic Eye Pain Business (2018-2023)
11.10.5 Spectra Vision Care Recent Development
11.11 AlconLaboratories
11.11.1 AlconLaboratories Company Detail
11.11.2 AlconLaboratories Business Overview
11.11.3 AlconLaboratories Neuropathic Eye Pain Introduction
11.11.4 AlconLaboratories Revenue in Neuropathic Eye Pain Business (2018-2023)
11.11.5 AlconLaboratories Recent Development
11.12 BRIM Biotechnology Inc
11.12.1 BRIM Biotechnology Inc Company Detail
11.12.2 BRIM Biotechnology Inc Business Overview
11.12.3 BRIM Biotechnology Inc Neuropathic Eye Pain Introduction
11.12.4 BRIM Biotechnology Inc Revenue in Neuropathic Eye Pain Business (2018-2023)
11.12.5 BRIM Biotechnology Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock